Diabetes Mellitus and Cardiovascular Disease

Nursing Clinics of North America

Volumn 41, Issue 4, 2006, Pages 681-695

  Chyun, Deborah A ^a   Young, Lawrence H ^b  

^a YALE UNIVERSITY SCHOOL OF NURSING   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; CHRONIC DISEASE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; HUMAN; REVIEW;

CARDIOVASCULAR DISEASES; CHRONIC DISEASE; CORONARY DISEASE; DIABETES COMPLICATIONS; HUMANS;

EID: 33750198664     PISSN: 00296465     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cnur.2006.07.007     Document Type: Review

References (45)

1. Kannel W.B., and McGee D.L. Diabetes and cardiovascular risk factors: the Framingham Study. Circulation 2 (1979) 8-13
2. Fox S., Coady S., Sorlie P.D., et al. Trends in cardiovascular complications of diabetes. JAMA 292 (2004) 2495-2499
3. Hu F.B., Stampfer M.J., Solomon C.G., et al. The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women. Arch Intern Med 161 (2001) 1721-1723
4. United Kingdom Prospective Diabetes (UKPDS) Group. Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 (1998) 837-853
5. Grundy S.M., Cleeman J.I., Daniels S.R., et al. Diagnosis and management of the metabolic syndrome. Circulation 112 (2005) 2735-2752
6. Young L.H., and Chyun D.A. Heart disease in patients with diabetes. In: Porte D., Baron A., and Sherwin R.S. (Eds). Ellenberg and Rifkin's diabetes mellitus: theory and practice. 6th edition (2002), McGraw-Hill, New York 823-844
7. Bertoni A.G., Bonds D.E., Hundley W.G., et al. Heart failure prevalence, incidence, and mortality in the elderly with diabetes. Diabetes Care 27 (2004) 699-703
8. Piccini J.P., Klein L., Gheorghiade M., et al. New insights into diastolic heart failure: role of diabetes mellitus. Am J Med 116 Suppl 5A (2004) 64S-75
9. The UKPDS Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 317 (1998) 703-713
10. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353 (2005) 2643-2653
11. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 28 (2005) S4-S36
12. Grundy S.M., Howard B., Smith S., et al. Prevention conference VI: Diabetes and cardiovascular disease. Circulation 105 (2002) 2231-2239
13. Low P.A., Benrud-Larson L.M., Sletten D.M., et al. Autonomic symptoms and diabetic neuropathy. Diabetes Care 27 (2004) 2942-2947
14. Maser R.E., Vinik A.I., Mitchell B.D., et al. The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes. Diabetes Care 26 (2003) 1895-1901
15. Ewing D.J., Borsey D.Q., Bellavere F., et al. Cardiac autonomic neuropathy in diabetes: comparison of measures of R-R interval variation. Diabetologia 21 (1981) 18-24
16. O'Brien I.A., O'Hare P., and Corrall R.J.M. Heart rate variability in healthy subjects: effects of age and the derivation of normal ranges for tests of autonomic function. Br Heart J 55 (1986) 348-354
17. Herzog R, Chyun DA, Young LH. Cardiovascular autonomic neuropathy. Practical Diabet, in press.
18. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Circulation 93 (1996) 1043-1065
19. Vinik A.I., Mitchell B.D., Maser R.E., et al. Diabetic autonomic neuropathy. Diabetes Care 26 (2003) 1895-1901
20. Wackers F.J.T.H., Young L.H., Inzucchi S.E., et al. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD Study. Diabetes Care 27 (2004) 1954-1961
21. Boulton A.J.M., Vinik A.I., Arezzo J.C., et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 28 (2005) 956-962
22. American Diabetes Association. Consensus development conference on the diagnosis of coronary heart disease in people with diabetes. Diabetes Care 21 (1998) 1551-1559
23. Gaede P., Vedel P., Larsen N., et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 348 (2003) 383-393
24. Roffi M., and Topol E.J. Percutaneous coronary intervention in diabetes patients with non-ST-segment elevation acute coronary syndromes. Eur Heart J 25 (2004) 190-198
25. Braunwald E., Antman E.M., Beasley J.W., et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction - summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on the management of patients with unstable angina). J Am Coll Cardiol 40 (2002) 1366-1374
26. Antman E.M., Anbe D.T., Armstrong P.W., et al. ACC/AHA Guidelines for the management of patients with ST-elevation myocardial infarction: executive summary. Circulation 110 (2004) 588-636
27. Gilbert J., Raboud J., and Zinman B. Meta-analysis of the effect of diabetes on restenosis rates among patients receiving coronary angioplasty stenting. Diabetes Care 27 (2004) 990-994
28. Abizaid A., Costa M.A., Centemero M., et al. Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients: insights for the Arterial Revascularization Therapy Study (ARTS) Trial. Circulation 104 (2001) 533-540
29. McAlister F.A., Man J., Bistritz L., et al. Diabetes and coronary artery bypass surgery. Diabetes Care 26 (2003) 1518-1524
30. Lazar HL, Chipkin SR, Fitzgerald CA, et al. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation 2004;109:1497-502.
31. Stranders I., Diamant M., van Gelder R.E., et al. Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes. Arch Intern Med 164 (2004) 982-988
32. Clement S., Braithwaite S.S., Magee M.F., et al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care 27 (2004) 553-591
33. Goldberg P.A., Siegel M.D., Sherwin R.S., et al. Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. Diabetes Care 27 (2004) 461-467
34. Choi D., Kim S.K., Choi S.H., et al. Preventive effects of rosiglitazone on restenosis after coronary stent implantation in patients with type 2 diabetes. Diabetes Care 27 (2004) 2654-2660
35. McGuire D.K., Newby L.K., Bhapkar M.V., et al. Association of diabetes mellitus and glycemic control strategies with clinical outcomes after acute coronary syndromes. Am Heart J 147 (2004) 246-252
36. Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 355 (2000) 253-259
37. Bhatt D.L., Fox K.A.A., Hacke W., et al. Clopidogrel and aspirin versus aspirin alone for prevention of atherothrombotic events. N Engl J Med 354 (2006) 1706-1717
38. Iribarren C., Karter A.J., Go A.S., et al. Glycemic control and heart failure among adult patients with diabetes. Circulation 103 (2001) 2668-2673
39. Bibbins-Domingo K., Lin F., Vittinghoff E., et al. Predictors of heart failure among women with coronary disease. Circulation 110 (2004) 1424-1430
40. Hunt S.A., Abraham W.T., Chin M.H., et al. American College of Cardiology/American Heart Association 2005 Guideline update for the diagnosis and management of chronic heart failure in the adult - summary article: a report of the ACC/AHA Task Force on Practice Guidelines. Circulation 112 (2005) 1825-1852
41. Barnett A., Bain S., Bouter C., et al. Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy. N Engl J Med 351 (2004) 1952-1961
42. Haas S.J., Vos T., Gilbert R.E., et al. Are beta-blockers as efficacious in patients with diabetes mellitus as in patients without diabetes mellitus who have chronic heart failure? A meta-analysis of large-scale clinical trials. Am Heart J 146 (2003) 848-853
43. Zile M.R., and Brutsaert D.L. New concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatment. Circulation 105 (2002) 1503-1508
44. Masoudi F.A., Inzucchi S.E., Wang Y., et al. Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure. Circulation 111 (2005) 583-590
45. Nesto R.W., LeWinter M., Bell D., et al. Thiazolidinedione use, fluid retention, and congestive heart failure. Diabetes Care 27 (2004) 256-263